ArticlemedRxiv : the preprint server for health sciences2025
Alcohol use disorder and epileptogenesis in primary malignant brain tumors: temporal and tumor grade associations in a nationwide EHR cohort study.
Article in medRxiv : the preprint server for health sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Updated by
Authors and funding
5 authors.
Funding
Abstract
Background: Primary malignant brain tumors (PMBTs), including glioblastomas (GBM) and low-grade gliomas (LGGs), frequently cause seizures, which worsen patient morbidity and quality of life. Alcohol use disorder (AUD) is a known risk factor for seizures in the general population, but its role in PMBT-associated seizures remains poorly understood. Objective: To evaluate the association between AUD and seizure prevalence in PMBT patients, and to examine whether this relationship varies by age, sex, race/ethnicity, and tumor grade. Methods: We conducted a retrospective cohort study using the Cosmos EHR database (2015-2025), identifying 244,955 adult patients with PMBTs. Seizure/epilepsy and AUD diagnoses were ascertained via ICD-10 codes. Associations were assessed using chi-square tests and logistic regression (adjusting for age, sex, and race). Temporal sequencing of AUD and seizure diagnoses was analyzed in six-month intervals. Subgroup analyses were performed for glioma grade (low vs. high). Results: PMBT patients with seizures were nearly twice as likely to have AUD compared to those without (OR = 1.90, 95% CI 1.83-1.97, p < 0.001). After adjusting for demographics, AUD remained significantly associated with seizure risk (OR = 1.37, 95% CI 1.24-1.51, p < 0.001). This association was strongest in younger patients and present across all sexes and racial groups. Temporal analyses indicated that AUD partly preceded seizure onset. Among patients with available histologic data, alcohol-using low-grade patients exhibited a markedly higher seizure prevalence compared to high-grade patients (43.8% vs. 12.1%, p < 0.001). Conclusions: AUD is potentially associated with increased seizure risk in PMBT patients, with a stronger effect in younger individuals and low-grade tumors. These findings suggest that alcohol-related hyperexcitability may compound tumor-associated epileptogenesis, highlighting AUD as a potentially modifiable risk factor. Prospective studies are warranted to confirm these relationships and to evaluate interventions targeting alcohol use for seizure mitigation.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.